Using the levy in order to finance recurring expenditures : the case of the International Drug Purchase Facility-UNITAID Meeting of experts on the solidarity contribution on airline tickets 29 June PARIS

2 Universal access to treatments in 2010: How can we fulfil our commitments?  Despite our efforts, there is still more to be done:  Only slightly more than 1 million people have access to anti-retroviral treatments while 6.5 million are in urgent need of treatment.  Very ambitious commitments have been made:  The international community in September 2005 renewed the commitment that was made at the Gleneagles G8 Summit « to provide as close as possible to universal access by 2010 for all those in need ».  These commitments raise three challenges:  Obtaining additional resources to fight these three diseases  Strengthening infrastructures and health systems  Increasing access to treatments in a global market

3 UNITAID / IDPF needs sustainable and predictable ressources so as to:  Broaden the funding supply:  Only sustainable and predictable resources can provide the pharmaceutical industry with solvent markets over the long term and secure the launch of large-scale programmes for access to treatment in developing countries.  Improve the security and the solvency of demand:  To increase the production of low-cost drugs, it is essential to secure markets for the pharmaceutical industry over the long term and to diversify supply.  Encourage price reductions and diversification of supply:  Prices are still too high for drugs for developing countries (second-line anti- retroviral drugs, anti-malarial treatments). Some treatments are not adapted to needs (insufficient formulae for paediatrics, combined set drugs).  Ensure the quality of drugs  The quality of drugs should meet international requirements.  UNITAID / IDPF will be financed either by the proceeds of international solidarity levies, or by perennial budgetary contributions

4 Functional Arrangements of UNITAID / IDPF  The UNITAID / IDPF can ensure:  For beneficiary countries: an uninterrupted supply of pre-qualified products at reduced prices.  For the pharmaceutical industry: demand forecasting to guide production, guaranteed funding orders, quality assurance in order to better adapt products to needs.  The UNITAID / IDPF could:  Negotiate competitive prices for countries or institutions buying drugs.  Group purchases wherever this solution has advantages and where a mandate has been given to do so.  Prevent the interruption of supply by establishing buffer stocks.

5 UNITAID / IDPF has reached a critical milestone  Brazil, Chile, Norway and France officially launched the UNITAID / IDPF in New-York at the United Nations on June 2 nd A Joint Declaration was issued outlining the mission, key principles and objectives of the UNITAID / IDPF.  Since the Joint Declaration in New-York on June 2 nd 2006, the IDPF – UNITAID has achieved significant progress in operationalizing its activities.  UNITAID / IDPF will focus on targeted actions where it can reach the greatest impact.  There is a consensus among partners on the urgency to scale up efforts in order to increase access to treatment to fight HIV–AIDS, malaria and tuberculosis.  International organizations, NGOs and private foundations (WHO, UNICEF, the Global Fund, the Clinton HIV/AIDS Initiative, UNAIDS, the Stop TB Partnership, Roll Back Malaria, MSF…) have worked jointly in order to make a first estimate of the needs and how UNITAID / IDPF could possibly help.

6 UNITAID / IDPF : next steps  UNITAID / IDPF will propose in September a definitive governance structure including:  The process and procedures.  The organization chart and accompanying baggage that show who reports to whom and how tasks are both divided and integrated.  The staffing.  Indications on the way managers will collectively behave with respect to use of time, attention, and symbolic actions.  The shared values that will drive the organization and will be common to most of its members.  Official launching of UNITAID / IDPF is to be announced at the time of the UN General Assembly in mid-September.